Quick Summary:
In the fast-paced realm of modern healthcare, the value of innovative diagnostic tools like biomarker technologies cannot be understated. Leveraging genetic markers like DNA and RNA, biomarker technologies serve as the front line of disease detection, especially for serious conditions such as cancer, cardiovascular diseases, neurological and autoimmune diseases. With wide application possibilities in drug discovery and disease management, biomarker technologies find themselves at the nexus of early diagnosis and treatment.
Accurate patient stratification and objective physiological and behavioral data collection are only a couple of the groundbreaking advancements seen in biomarker technology. Couple these with the continual expansion of healthcare infrastructure across developing regions, and it's easy to see major potential for growth in this field. With digital biomarkers incorporating AI and big data decision-making, the future of diagnosis and treatment could lie in biomarkers. Medical institutions and business executives can garner important insights from this global biomarker technologies market report, highlighting test types, indications, applications, and key industry players. Stay updated on trends in biomarker advancements and equip your organization with the tools for a proactive approach to healthcare.
The global biomarker technologies market size reached US$ 31.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 67.7 Billion by 2027, exhibiting a CAGR of 13.84% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Biomarker technologies are reliable and cost-effective detection tools that rely on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), for detecting pathogens. These technologies find extensive application in the early diagnosis of different diseases and disorders. They are also utilized in the drug discovery and development processes and the management of nervous system disorders, cardiovascular diseases, infections, immunological and genetic disorders, and cancer. Some of the commonly used biomarker technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS) and immunoassay.
Biomarker technologies are reliable and cost-effective detection tools that rely on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), for detecting pathogens. These technologies find extensive application in the early diagnosis of different diseases and disorders. They are also utilized in the drug discovery and development processes and the management of nervous system disorders, cardiovascular diseases, infections, immunological and genetic disorders, and cancer. Some of the commonly used biomarker technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS) and immunoassay.
Biomarker Technologies Market Trends:
There is currently a considerable rise in the number of individuals who are suffering from cancer and cardiovascular, neurological, and autoimmune diseases across the globe. This, coupled with the escalating demand for early and effective diagnosis, represents one of the key factors positively influencing the market. Apart from this, the rising geriatric population is also contributing to the growth of the market. Moreover, there is an increase in research and development (R&D) funding for drug discovery by governing agencies of numerous countries. This, along with the considerably expanding healthcare infrastructure, especially in developing countries, is propelling the market growth. Furthermore, leading market players are introducing numerous advancements in biomarker technologies that provide accurate patient stratification. They are also developing digital biomarkers that aid in collecting objective, quantifiable, physiological, and behavioral data by using digital devices. These digital biomarkers are also incorporated with artificial intelligence (AI), machine learning (ML) solutions for big data analysis, and integrated decision making. Other major factors, including rising awareness about the early detection of cancer for better treatment, and surging income levels of individuals, are projected to impel the market growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global biomarker technologies market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on test type, indication, product, technology and application.Breakup by Test Type:
- Solid Biopsy
- Liquid Biopsy
Breakup by Indication:
- Cancer
- Infectious Diseases
- Autoimmune Disorders
- Cardiovascular Disorders
- Others
Breakup by Product:
- Consumables
- Assay
- Reagent
- Instruments
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Immunoassay
- Others
Breakup by Application:
- Drug Discovery
- Clinical Diagnostics
- Personalized Medicine
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation.Key Questions Answered in This Report:
- How has the global biomarker technologies market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global biomarker technologies market?
- What are the key regional markets?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global biomarker technologies market and who are the key players?
- What is the degree of competition in the industry?
Frequently Asked Questions about the Global Biomarker Technologies Market
What is the estimated value of the Global Biomarker Technologies Market?
What is the growth rate of the Global Biomarker Technologies Market?
What is the forecasted size of the Global Biomarker Technologies Market?
Who are the key companies in the Global Biomarker Technologies Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | October 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 31.1 Billion |
| Forecasted Market Value ( USD | $ 67.7 Billion |
| Compound Annual Growth Rate | 13.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Biomarker Technologies Market
6 Market Breakup by Test Type
7 Market Breakup by Indication
8 Market Breakup by Product
9 Market Breakup by Technology
10 Market Breakup by Application
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Illumina Inc.
- LI-COR Inc.
- Merck KGaA
- PerkinElmer Inc.
- QIAGEN N.V.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation.
Methodology
LOADING...
